{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:01:44Z","timestamp":1794859304692,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Two eco-friendly, facile, rapid, and highly sensitive analytical methodologies were developed for the concurrent estimation of melatonin and zolpidem tartrate in raw materials and dosage forms. The first approach is a green first derivative synchronous spectrofluorimetric method (Method I), utilizing a wavelength interval (\u0394\u03bb) of 60\u00a0nm and capturing derivative signals at 265.0\u00a0nm and 339.0\u00a0nm for melatonin and zolpidem, respectively. Method I exhibited excellent linearity over the ranges of 8.0\u201370.0 ng\/mL for melatonin and 10.0\u201380.0 ng\/mL for zolpidem, with detection limits of 1.62 ng\/mL and 1.19 ng\/mL. The second method (Method II) involves high-performance liquid chromatography coupled with fluorescence detection (HPLC-FD), employing a C18 column and a mobile phase of methanol:0.05% triethylamine (70:30, v\/v, pH 5.5) at a flow rate of 1.0 mL\/min. Fluorescence detection was performed at 383\u00a0nm following excitation at 243\u00a0nm. This method achieved linearity within 150.0\u20131500.0 ng\/mL for melatonin and 50.0\u2013700.0 ng\/mL for zolpidem, with detection limits of 18.87 ng\/mL and 8.86 ng\/mL, respectively. Both methods were rigorously validated in accordance with ICH Q2(R1) guidelines, demonstrating high accuracy, precision, and robustness in analyzing commercial dosage forms. Greenness and sustainability were quantitatively assessed using the AGREE and eco-scale metrices, while method applicability and performance were evaluated using the Blue Applicability Grade Index (BAGI), affirming both techniques as efficient and environmentally sustainable tools for routine quality control.<\/jats:p>","DOI":"10.1038\/s41598-025-18325-y","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T11:11:53Z","timestamp":1758193913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Eco-friendly spectrofluorimetric and HPLC-fluorescence methods for simultaneous determination of melatonin and zolpidem in pharmaceuticals"],"prefix":"10.1038","volume":"15","author":[{"given":"Shrouk M.","family":"Abo Elkheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Jeehan M.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.","family":"Walash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah M.","family":"Zeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"18325_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.smrv.2004.05.002","volume":"9","author":"J Arendt","year":"2005","unstructured":"Arendt, J. & Skene, D. J. Melatonin as a chronobiotic. Sleep Med. Rev. 9, 25\u201339 (2005).","journal-title":"Sleep Med. Rev."},{"key":"18325_CR2","first-page":"404","volume":"24","author":"V Csernus","year":"2003","unstructured":"Csernus, V. & Mess, B. Biorhythms and pineal gland. Neuroendocrinol. Lett. 24, 404\u2013411 (2003).","journal-title":"Neuroendocrinol. Lett."},{"key":"18325_CR3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/S0959-8049(99)00159-8","volume":"35","author":"P Lissoni","year":"1999","unstructured":"Lissoni, P. et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur. J. Cancer. 35, 1688\u20131692 (1999).","journal-title":"Eur. J. Cancer"},{"key":"18325_CR4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1136\/gut.2004.062034","volume":"54","author":"GH Song","year":"2005","unstructured":"Song, G. H., Leng, P. H., Gwee, K. A., Moochhala, S. M. & Ho, K. Y. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 54, 1402\u20131407 (2005).","journal-title":"Gut"},{"key":"18325_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-079X.2006.00359.x","volume":"41","author":"RS Pereira","year":"2006","unstructured":"Pereira, R. S. Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with Omeprazole. J. Pineal Res. 41, 195\u2013200 (2006).","journal-title":"J. Pineal Res."},{"key":"18325_CR6","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.yfrne.2022.100986","volume":"65","author":"J Roy","year":"2022","unstructured":"Roy, J. et al. Role of melatonin in alzheimer\u2019s disease: from preclinical studies to novel melatonin-based therapies. Front. Neuroendocr. 65, 100986 (2022).","journal-title":"Front. Neuroendocr."},{"key":"18325_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2021.01.034","volume":"93","author":"JH Cho","year":"2021","unstructured":"Cho, J. H., Bhutani, S., Kim, C. H. & Irwin, M. R. Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials. Brain. Behav. Immun. 93, 245\u2013253 (2021).","journal-title":"Brain. Behav. Immun."},{"key":"18325_CR8","unstructured":"The British Pharmacopoeia (The Stationary Office, 2013)."},{"key":"18325_CR9","unstructured":"U.S.P. Convention. USP 33 NF 28: United States Pharmacopeia [and] National Formulary (United States Pharmacopeial Convention, 2010)."},{"key":"18325_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0003-2670(03)00662-7","volume":"488","author":"V Pucci","year":"2003","unstructured":"Pucci, V., Ferranti, A., Mandrioli, R. & Raggi, M. A. Determination of melatonin in commercial preparations by micellar electrokinetic chromatography and spectrofluorimetry. Anal. Chim. Acta. 488, 97\u2013105 (2003).","journal-title":"Anal. Chim. Acta"},{"key":"18325_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.farmac.2005.03.009","volume":"60","author":"MH Sorouraddin","year":"2005","unstructured":"Sorouraddin, M. H., Rashidi, M. R., Ghorbani-Kalhor, E. & Asadpour-Zeynali, K. Simultaneous spectrofluorimetric and spectrophotometric determination of melatonin and pyridoxine in pharmaceutical preparations by multivariate calibration methods. Il Farmaco. 60, 451\u2013458 (2005).","journal-title":"Il Farmaco"},{"key":"18325_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-153X-6-1","volume":"6","author":"HW Darwish","year":"2012","unstructured":"Darwish, H. W., Attia, M. I. & Zlotos, D. P. New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino) ethyl]-5-methoxy-1H-indol-2-yl} methyl)-5-methoxy-1H-indol-3-yl]-ethyl} acetamide: a contaminant in commercial melatonin preparations. Chem. Cent. J. 6, 1\u201311 (2012).","journal-title":"Chem. Cent. J."},{"key":"18325_CR13","doi-asserted-by":"publisher","first-page":"123309","DOI":"10.1016\/j.saa.2023.123309","volume":"304","author":"H Kumar","year":"2024","unstructured":"Kumar, H. & Obrai, S. Ratiometric fluorescent sensing of melatonin based on inner filter effect and smartphone established detection. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 304, 123309 (2024).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"18325_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s006040070021","volume":"135","author":"AS Amin","year":"2000","unstructured":"Amin, A. S., Zaky, M. & El-Beshbeshy, A. M. Colorimetric Estimation of melatonin in pharmaceutical formulations. Microchim. Acta. 135, 81\u201385 (2000).","journal-title":"Microchim. Acta"},{"key":"18325_CR15","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1081\/AL-120016104","volume":"35","author":"B Uslu","year":"2002","unstructured":"Uslu, B., \u00d6zkan, S. A. & Aboul-Enein, H. Y. Spectrophotometric determination of melatonin and pyridoxine HCL in binary mixture using first derivative of the ratio spectra method. Anal. Lett. 35, 2305\u20132317 (2002).","journal-title":"Anal. Lett."},{"key":"18325_CR16","unstructured":"Venkatachalam, T. & Lalitha, K. Spectrophotometric methods for simultaneous estimation of melatonin and zolpidem from the combined tablet dosage form. Pharmacophore 5 (2014)."},{"key":"18325_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5455\/spatula.20120906112559","volume":"2","author":"J Lin","year":"2012","unstructured":"Lin, J., Zhang, C., Gao, Y., Zhao, X. & Li, X. A validated HPLC method for determining melatonin in capsule dosage form. Spatula DD. 2, 147\u2013151 (2012).","journal-title":"Spatula DD"},{"key":"18325_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0378-4347(96)00051-5","volume":"681","author":"AA Vitale","year":"1996","unstructured":"Vitale, A. A., Ferrari, C. C., Aldana, H. & Affanni, J. M. Highly sensitive method for the determination of melatonin by normal-phase high-performance liquid chromatography with fluorometric detection. J. Chromatogr. B Biomed. Sci. Appl. 681, 381\u2013384 (1996).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"18325_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.12991\/mpj.2017.16","volume":"21","author":"GA AZ\u0130ZO\u011eLU","year":"2017","unstructured":"Az\u0130zo\u011flu, G. A., Az\u0130zo\u011flu, E., Tanriverd\u0130, S. T. & \u00d6zgen, \u00d6. A validated HPLC method for simultaneous Estimation of melatonin and octyl methoxycinnamate in combined pharmaceutical applications. Marmara Pharm. J. 21, 921\u2013930 (2017).","journal-title":"Marmara Pharm. J."},{"key":"18325_CR20","first-page":"240","volume":"4","author":"G Akula","year":"2015","unstructured":"Akula, G., Talari, Y., Phanindra, S. & Akula, G. Method development and validation for simultaneous Estimation of melatonin and Zolpidem tartrate by using RP-HPLC. Sch. Acad. J. Pharm. 4, 240\u2013244 (2015).","journal-title":"Sch. Acad. J. Pharm."},{"key":"18325_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7897\/2230-8407.09348","volume":"9","author":"A Sattar","year":"2018","unstructured":"Sattar, A. & Suneetha, A. A validated RP-HPLC method for the determination of melatonin and Zolpidem tartarate in bulk and pharmaceutical dosage forms. Int. Res. J. Pharm. 9, 90\u201396 (2018).","journal-title":"Int. Res. J. Pharm."},{"key":"18325_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0003-2670(99)00809-0","volume":"408","author":"G Chen","year":"2000","unstructured":"Chen, G., Ding, X., Cao, Z. & Ye, J. Determination of melatonin and pyridoxine in pharmaceutical preparations for health-caring purposes by capillary electrophoresis with electrochemical detection. Anal. Chim. Acta. 408, 249\u2013256 (2000).","journal-title":"Anal. Chim. Acta"},{"key":"18325_CR23","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/jssc.200500095","volume":"28","author":"E Pobo\u017cy","year":"2005","unstructured":"Pobo\u017cy, E., Michalski, A., Sotowska-Brochocka, J. & Trojanowicz, M. Determination of melatonin and its precursors and metabolites using capillary electrophoresis with UV and fluorometric detection. J. Sep. Sci. 28, 2165\u20132172 (2005).","journal-title":"J. Sep. Sci."},{"key":"18325_CR24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.chroma.2009.12.070","volume":"1217","author":"D Hevia","year":"2010","unstructured":"Hevia, D. et al. Development and validation of new methods for the determination of melatonin and its oxidative metabolites by high performance liquid chromatography and capillary electrophoresis, using multivariate optimization. J. Chromatogr. A. 1217, 1368\u20131374 (2010).","journal-title":"J. Chromatogr. A"},{"key":"18325_CR25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00604-015-1520-x","volume":"182","author":"FJV Gomez","year":"2015","unstructured":"Gomez, F. J. V., Mart\u00edn, A., Silva, M. F. & Escarpa, A. Screen-printed electrodes modified with carbon nanotubes or graphene for simultaneous determination of melatonin and serotonin. Microchim. Acta. 182, 1925\u20131931 (2015).","journal-title":"Microchim. Acta"},{"key":"18325_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2147\/IJN.S104941","volume":"11","author":"IM Apetrei","year":"2016","unstructured":"Apetrei, I. M. & Apetrei, C. Voltammetric determination of melatonin using a graphene-based sensor in pharmaceutical products. Int. J. Nanomed. 11, 1859 (2016).","journal-title":"Int. J. Nanomed."},{"key":"18325_CR27","unstructured":"Sweetman, S. C. Martindale: The Complete Drug Reference (Pharmaceutical Press, 2009)."},{"key":"18325_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/0975-7406.72142","volume":"2","author":"R Chomwal","year":"2010","unstructured":"Chomwal, R., Kumar, A. & Goyal, A. Spectrophotometric methods for determination of Zolpidem tartrate in tablet formulation. J. Pharm. Bioallied Sci. 2, 365 (2010).","journal-title":"J. Pharm. Bioallied Sci."},{"key":"18325_CR29","first-page":"1","volume":"2","author":"K Patil","year":"2010","unstructured":"Patil, K., Pore, Y. & Bhise, S. Spectrophotometric Estimation of Zolpidem in tablets. J. Pharm. Sci. Res. 2, 1 (2010).","journal-title":"J. Pharm. Sci. Res."},{"key":"18325_CR30","first-page":"096","volume":"2","author":"MM Annapurna","year":"2012","unstructured":"Annapurna, M. M., Swathi, B., Chandra, M. S. & Tulasi, K. Derivative spectrophotometric methods for the determination of Zolpidem tartrate in tablets. J. Appl. Pharm. Sci. 2, 096\u2013099 (2012).","journal-title":"J. Appl. Pharm. Sci."},{"key":"18325_CR31","first-page":"917","volume":"4","author":"M Naidu","year":"2011","unstructured":"Naidu, M., Venkatesh, D. & Chakravarthy, I. Spectrophotometric analysis of Zolpidem tartrate in pharmaceutical formulation. Res. J. Pharm. Technol. 4, 917\u2013919 (2011).","journal-title":"Res. J. Pharm. Technol."},{"key":"18325_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0378-4347(00)83462-3","volume":"383","author":"P Guinebault","year":"1986","unstructured":"Guinebault, P., Dubruc, C., Hermann, P. & Th\u00e9not, J. High-performance liquid chromatographic determination of zolpidem, a new sleep inducer, in biological fluids with fluorimetric detection. J. Chromatogr. B Biomed. Sci. Appl. 383, 206\u2013211 (1986).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"18325_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jat\/21.5.388","volume":"21","author":"ALB Durol","year":"1997","unstructured":"Durol, A. L. B. & Greenblatt, D. J. Analysis of Zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: application to single-dose Pharmacokinetic studies. J. Anal. Toxicol. 21, 388\u2013392 (1997).","journal-title":"J. Anal. Toxicol."},{"key":"18325_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0731-7085(99)00311-8","volume":"22","author":"PR Ring","year":"2000","unstructured":"Ring, P. R. & Bostick, J. M. Validation of a method for the determination of Zolpidem in human plasma using LC with fluorescence detection. J. Pharm. Biomed. Anal. 22, 495\u2013504 (2000).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"18325_CR35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1134\/S1061934815060143","volume":"70","author":"S Yaripour","year":"2015","unstructured":"Yaripour, S., Rashid, S. N., Alibakhshi, H. & Mohammadi, A. Development and validation of a stability-indicating reversed phase HPLC method for the quality control of Zolpidem in bulk and tablet dosage forms. J. Anal. Chem. 70, 738\u2013743 (2015).","journal-title":"J. Anal. Chem."},{"key":"18325_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0378-4347(95)00342-8","volume":"675","author":"G Hempel","year":"1996","unstructured":"Hempel, G. & Blaschke, G. Direct determination of Zolpidem and its main metabolites in urine using capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 675, 131\u2013137 (1996).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"18325_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3797\/scipharm.1401-11","volume":"82","author":"KM Al Azzam","year":"2014","unstructured":"Al Azzam, K. M., Yit, L. K., Saad, B. & Shaibah, H. Development and validation of a stability-indicating capillary electrophoresis method for the determination of Zolpidem tartrate in tablet dosage form with positive confirmation using 2D-and 3D-DAD fingerprints. Sci. Pharm. 82, 341\u2013356 (2014).","journal-title":"Sci. Pharm."},{"key":"18325_CR38","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1248\/cpb.52.1063","volume":"52","author":"AE Radi","year":"2004","unstructured":"Radi, A. E., Bekhiet, G. & Wahdan, T. Electrochemical study of Zolpidem at glassy carbon electrode and its determination in a tablet dosage form by differential pulse voltammetry. Chem. Pharm. Bull. 52, 1063\u20131065 (2004).","journal-title":"Chem. Pharm. Bull."},{"key":"18325_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.33961\/JECST.2016.7.1.68","volume":"7","author":"A Naeemy","year":"2016","unstructured":"Naeemy, A., Sedighi, E. & Mohammadi, A. Electrooxidation of Zolpidem and its voltammetric quantification in standard and pharmaceutical formulation using pencil graphite electrode. J. Electrochem. Sci. Technol. 7, 68\u201375 (2016).","journal-title":"J. Electrochem. Sci. Technol."},{"key":"18325_CR40","first-page":"458","volume":"12","author":"E Naghian","year":"2020","unstructured":"Naghian, E. & Sohouli, E. A new electrochemical sensor for determination of Zolpidem by carbon paste electrode modified with sns@ SnO2NP. Anal. Bioanal. Electrochem. 12, 458\u2013467 (2020).","journal-title":"Anal. Bioanalytical Electrochem."},{"key":"18325_CR41","doi-asserted-by":"publisher","first-page":"101945","DOI":"10.1016\/j.mtcomm.2020.101945","volume":"26","author":"E Sohouli","year":"2021","unstructured":"Sohouli, E. et al. Sensitive sensor based on TiO2NPs nano-composite for the rapid analysis of zolpidem, a psychoactive drug with cancer-causing potential. Mater. Today Commun. 26, 101945 (2021).","journal-title":"Mater. Today Commun."},{"key":"18325_CR42","doi-asserted-by":"publisher","first-page":"122986","DOI":"10.1016\/j.jns.2024.122986","volume":"460","author":"NH Barad","year":"2024","unstructured":"Barad, N. H. & Mulroy, E. Successful treatment of cranial dystonia using a Zolpidem\u2009+\u2009Melatonin combination: A video case-series. J. Neurol. Sci. 460, 122986 (2024).","journal-title":"J. Neurol. Sci."},{"key":"18325_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/bio.2386","volume":"28","author":"MS El-Din","year":"2013","unstructured":"El-Din, M. S., Eid, M. & Zeid, A. M. Simultaneous determination of methocarbamol and aspirin by RP-HPLC using fluorescence detection with time programming: its application to pharmaceutical dosage form. Luminescence 28, 332\u2013338 (2013).","journal-title":"Luminescence"},{"key":"18325_CR44","doi-asserted-by":"publisher","first-page":"123532","DOI":"10.1016\/j.saa.2023.123532","volume":"305","author":"H Abd El-Aziz","year":"2024","unstructured":"Abd El-Aziz, H. & Zeid, A. M. Derivatization-free conventional and synchronous spectrofluorimetric Estimation of Atenolol and amlodipine. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 305, 123532 (2024).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"18325_CR45","doi-asserted-by":"publisher","first-page":"125344","DOI":"10.1016\/j.saa.2024.125344","volume":"327","author":"MA El Hamd","year":"2025","unstructured":"El Hamd, M. A., Mahdi, W. A., Alshehri, S., Alsehli, B. R. & Abu-Hassan, A. A. Streamlined turn-off fluorescence sensing of donepezil: enhancing evaluation in pharmaceutical formulations, quality control labs, and biological fluids at nano levels. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 327, 125344 (2025).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"issue":"2","key":"18325_CR46","doi-asserted-by":"publisher","first-page":"e70120","DOI":"10.1002\/bio.70120","volume":"40","author":"AA Abu-hassan","year":"2025","unstructured":"Abu-hassan, A. A. et al. Spectacular application of Isoindole\u2010Based fluorophore for mirabegron assay in tablets and biological fluids (Urine\/Plasma). Assessment of method blueness and whiteness. Luminescence 40 (2), e70120 (2025).","journal-title":"Luminescence"},{"key":"18325_CR47","doi-asserted-by":"publisher","first-page":"122626","DOI":"10.1016\/j.saa.2023.122626","volume":"295","author":"R Aboshabana","year":"2023","unstructured":"Aboshabana, R., Zeid, A. M. & Ibrahim, F. A. Label-free green Estimation of Atenolol and ivabradine hydrochloride in pharmaceutical and biological matrices by synchronous spectrofluorimetry. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 295, 122626 (2023).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"18325_CR48","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/bio.4337","volume":"37","author":"SM Abo Elkheir","year":"2022","unstructured":"Abo Elkheir, S. M., Zeid, A. M., Nasr, J. J. M. & Walash, M. I. First derivative synchronous spectrofluorimetric analysis of Bisoprolol fumarate and ivabradine in pharmaceutical and biological matrices. Investigation of the method greenness.\u00a0Luminescence. 37, 1657\u20131665 (2022).","journal-title":"Luminescence"},{"key":"18325_CR49","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1080\/10826076.2012.678028","volume":"36","author":"M. S El-Din","year":"2013","unstructured":"El-Din, M. S., Eid, M. & Zeid, A. M., simultaneous determination of methocarbamol and ibuprofen in their binary mixtures using Hplc method with fluorescence detection: application to combined tablets. J. Liq. Chromatogr. Relat. Technol. 36, 852\u2013866 (2013).","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"18325_CR50","unstructured":"Q.R. ICH Harmonized Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology, Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 (1996) (2005)."},{"key":"18325_CR51","unstructured":"Miller, J. & Miller, J. C. Statistics and Chemometrics for Analytical Chemistry (Pearson Education, 2018)."},{"key":"18325_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka, A., Migaszewski, Z. M., Konieczka, P. & Namie\u015bnik, J. Analytical Eco-Scale for assessing the greenness of analytical procedures. Trends Anal. Chem. 37, 61\u201372 (2012).","journal-title":"TRAC Trends Anal. Chem."},{"key":"18325_CR53","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical greenness metric approach and software. Anal. Chem. 92, 10076\u201310082 (2020).","journal-title":"Anal. Chem."},{"key":"18325_CR54","doi-asserted-by":"publisher","first-page":"100795","DOI":"10.1016\/j.scp.2022.100795","volume":"29","author":"AM Zeid","year":"2022","unstructured":"Zeid, A. M., El-Masry, A. A., El-Wasseef, D. R., Eid, M. & Shehata, I. A. Green microemulsion electrokinetic chromatographic method for simultaneous determination of azelastine and Budesonide. Sustainable Chem. Pharm. 29, 100795 (2022).","journal-title":"Sustainable Chem. Pharm."},{"key":"18325_CR55","doi-asserted-by":"publisher","first-page":"111320","DOI":"10.1016\/j.microc.2024.111320","volume":"205","author":"MA El Hamd","year":"2024","unstructured":"El Hamd, M. A. et al. Factorial design-aided derivatization-free fluorimetric ultrasensitive assay of Vonoprazan with application in uniformity of dosage units and plasma samples analysis: comprehensive and comparative greenness and whiteness assessment. Microchem. J. 205, 111320 (2024).","journal-title":"Microchem. J."},{"issue":"1","key":"18325_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13065-023-01094-y","volume":"17","author":"AA Abu-Hassan","year":"2023","unstructured":"Abu-Hassan, A. A. Nano-level assay of attention-deficit\/hyperactivity disorder medicament, Atomoxetine by molecular-size-based resonance Rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis. BMC Chem. 17 (1), 175 (2023).","journal-title":"BMC Chem."},{"key":"18325_CR57","doi-asserted-by":"publisher","first-page":"116203","DOI":"10.1016\/j.jphotochem.2024.116203","volume":"462","author":"AA Abu-hassan","year":"2025","unstructured":"Abu-hassan, A. A., Mahdi, W. A., Alshehri, S., Alsehli, B. R. & El Hamd, M. A. Innovative, eco-friendly fluorescence-quenching strategy for precise cyclopentolate evaluation in eye drops and aqueous humor-based enhanced ophthalmic care. J. Photochem. Photobiol., A. 462, 116203 (2025).","journal-title":"J. Photochem. Photobiol., A"},{"key":"18325_CR58","doi-asserted-by":"publisher","first-page":"124400","DOI":"10.1016\/j.saa.2024.124400","volume":"317","author":"AA Abu-Hassan","year":"2024","unstructured":"Abu-Hassan, A. A., Mahdi, W. A., Alshehri, S., Amin, M. M. & El Hamd, M. A. Facile and green chemistry-compatible fluorescence spectroscopic applications of acid red 87 used to evaluate eletriptan, antimigraine, in its pharmaceutical and biological samples. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 317, 124400 (2024).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"18325_CR59","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 25, 7598\u20137604 (2023).","journal-title":"Green Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18325-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:03:16Z","timestamp":1758196996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18325-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18325"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18325-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32598"}}